González-Romero, E.; Martínez-Valiente, C.; García-García, G.; Rosal-Vela, A.; Millán, J.M.; Sanz, M.Á.; Sanz, G.; Liquori, A.; Cervera, J.V.; Vázquez-Manrique, R.P.
PCR-Based Strategy for Introducing CRISPR/Cas9 Machinery into Hematopoietic Cell Lines. Cancers 2023, 15, 4263.
https://doi.org/10.3390/cancers15174263
AMA Style
González-Romero E, Martínez-Valiente C, García-García G, Rosal-Vela A, Millán JM, Sanz MÁ, Sanz G, Liquori A, Cervera JV, Vázquez-Manrique RP.
PCR-Based Strategy for Introducing CRISPR/Cas9 Machinery into Hematopoietic Cell Lines. Cancers. 2023; 15(17):4263.
https://doi.org/10.3390/cancers15174263
Chicago/Turabian Style
González-Romero, Elisa, Cristina Martínez-Valiente, Gema García-García, Antonio Rosal-Vela, José María Millán, Miguel Ángel Sanz, Guillermo Sanz, Alessandro Liquori, José Vicente Cervera, and Rafael P. Vázquez-Manrique.
2023. "PCR-Based Strategy for Introducing CRISPR/Cas9 Machinery into Hematopoietic Cell Lines" Cancers 15, no. 17: 4263.
https://doi.org/10.3390/cancers15174263
APA Style
González-Romero, E., Martínez-Valiente, C., García-García, G., Rosal-Vela, A., Millán, J. M., Sanz, M. Á., Sanz, G., Liquori, A., Cervera, J. V., & Vázquez-Manrique, R. P.
(2023). PCR-Based Strategy for Introducing CRISPR/Cas9 Machinery into Hematopoietic Cell Lines. Cancers, 15(17), 4263.
https://doi.org/10.3390/cancers15174263
